¹⁸F-fluorodeoxyglucose-PET as a biomarker in Huntington’s disease

By Ciarmiello Andrea   Squitieri Ferdinando  

Neurodegenerative Disease Management, Vol. 3, Iss. 6, 2013-12 ,pp. : 489-491

Future Medicine

Access to resources Recommend Favorite

Clinical utility of flumazenil-PET versus [ 18 F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients

By Ryvlin P   Bouvard S   Le Bars De   De Lamérie G   Grégoire MC   Kahane P   Froment JC   Mauguiére F  

Brain, Vol. 121, Iss. 11, 1998-11 ,pp. : 2067-2081

Oxford University Press

Access to resources Recommend Favorite

Localized oral amyloidosis of the palate

By Pentenero M.   Davico Bonino L.   Tomasini C.   Conrotto D.   Gandolfo S.  

Amyloid: The Journal of Protein Folding Disorders, Vol. 13, Iss. 1, 2006-03 ,pp. : 42-46

Informa Healthcare

Access to resources Recommend Favorite

18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review

By Mekinian Arsene   Jaccard Arnaud   Soussan Michael   Launay David   Berthier Sabine   Federici Laure   Lefèvre Guillaume   Valeyre Dominique   Dhote Robin   Fain Olivier  

Amyloid: The Journal of Protein Folding Disorders, Vol. 19, Iss. 2, 2012-06 ,pp. : 94-98

Informa Healthcare

Access to resources Recommend Favorite

Mild experimental ketosis increases brain uptake of ¹¹C-acetoacetate and ¹⁸F-fluorodeoxyglucose: a dual-tracer PET imaging study in rats

By Pifferi Fabien   Tremblay Sébastien   Croteau Etienne   Fortier Mélanie   Tremblay-Mercier Jennifer   Lecomte Roger   Cunnane Stephen C.  

Nutritional Neuroscience, Vol. 14, Iss. 2, 2011-03 ,pp. : 51-58

Maney Publishing

Access to resources Recommend Favorite